Registro:

Referencias:

• Adachi, H., Kurachi, H., Homma, H., Adachi, K., Takashi, I., Morishige, K., Matsuzawa, Y., Miyake, A., Epidermal growth factor promotes adipogenesis of 3T3-L1 cell in vitro (1994) Endocrinology, 135, pp. 1824-1830
• Ailhaud, G., Obesity and the adipocyte. Molecular mechanisms of adipocyte differentiation (1997) J Endocrinol, 155, pp. 201-202
• Boney, C.M., Moats-Staats, B.M., Stiles, A.D., D'Ercole, A.J., Expression of insulin-like growth factor-1 (IGF-1) and IGF-1 binding proteins during adipogenesis (1994) Endocrinology, 135, pp. 1863-1868
• Boney, C.M., Smith, R.M., Gruppuso, P.A., Modulation of insulin-like growth factor 1 mitogenic signaling in 3T3-L1 preadipocyte differentiation (1998) Endocrinology, 139, pp. 1638-1644
• Boney, C.M., Gruppuso, P.A., Faris, R.A., Frackelton Jr., A.R., The critical role of Shc in insulin-like growth factor-1-mediated mitogenesis and differentiation in 3T3-L1 preadipocytes (2000) Mol Endocrinol, 14, pp. 805-813
• Boney, C.M., Sekimoto, H., Gruppuso, P.A., Frackelton Jr., A.R., Src family tyrosine kinases participate in insulin-like growth factor 1 mitogenic signaling in 3T3-L1 cells (2001) Cell Growth Differ, 12, pp. 379-386
• Britsch, S., Li, L., Kirchhoff, S., Theuring, F., Brinkmann, V., Birchmeier, C., Riethmacher, D., The ErbB2 and ErbB3 receptors and their ligand, neuregulin-1, are essential for development of the sympathetic nervous system (1998) Genes Dev, 12, pp. 1825-1836
• Cornelius, P., MacDougald, O., Lane, M.D., Regulation of adipocyte development (1994) Annu Rev Nutr, 14, pp. 99-129
• Darcy, K.M., Wohlhueter, A.L., Zangani, D., Vaughan, M.M., Russell, J.A., Masso-Welch, P.A., Varela, S.M., Ip, M.M., Selective changes in EGF receptor expression and function during the proliferation, differentiation and apoptosis of mammary epithelial cells (1999) Eur J Cell Biol, 78, pp. 511-523
• Darcy, K.M., Zangani, D., Wohlhueter, A.L., Huang, R.Y., Vaughan, M.M., Russell, J.A., Ip, M.M., Changes in erbB2 (her-2/neu), erbB3, and erbB4 during growth, differentiation, and apoptosis of normal rat mammary epithelial cells (2000) J Histochem Cytochem, 48, pp. 63-80
• Engelman, J., Lisanti, M., Scherer, P., Specific inhibitors of p38 mitogen-activated protein kinase block 3T3-L1 adipogenesis (1998) J Biol Chem, 273, pp. 32111-32120
• Font de Mora, J., Porras, A., Ahn, N., Santos, E., Mitogen-activated protein kinase activation is not necessary for but antagonizes, 3T3-L1 differentiation (1997) Mol Cell Biol, 17, pp. 6068-6075
• Graus-Porta, D., Beerli, R.R., Daly, J.M., Hynes, N.E., ErbB-2, the preferred heterodimerization partner of all erbB receptors, is a mediator of lateral signaling (1997) EMBO J, 16, pp. 1647-1655
• Green, H., Kehinde, O., Sublines of mouse 3T3 cells that accumulate lipid (1974) Cell, 1, pp. 113-116
• Hardy, R., Gupta, K., MacDonald, J., Williford, J., Wells, A., Epidermal growth factor (EGF) receptor carboxy-terminal domains are required for EGF-induced glucose transport in transgenic 3T3-L1 adipocytes (1995) Endocrinology, 136, pp. 431-439
• Kim, S., Houtman, J.C.D., Jiang, J., Ruppert, M., Bertics, P.J., Frank, S.J., Growth hormone-induced alteration in erbB-2 phosphorylation status in 3T3-F442A fibroblasts (1999) J Biol Chem, 274, pp. 36015-36024
• Kokai, Y., Dobashi, K., Weiner, D., Myers, J., Nowell, P., Greene, M.I., Phosphorylation process induced by epidermal growth factor alters the oncogenic and cellular neu (NGL) gene products (1988) Proc Natl Acad Sci USA, 85, pp. 5389-5393
• Kurachi, H., Adachi, H., Ohtsuka, S., Morishige, K., Amemiya, K., Keno, Y., Shimomura, I., Tanizawa, O., Involvement of epidermal growth factor in inducing obesity in ovariectomized mice (1993) Am J Physiol, 265, pp. E323-E331
• Lee, K.F., Simon, H., Chen, H., Bates, B., Hung, M.C., Hauser, C., Requirement for neuregulin receptor erbB2 in neural and cardiac development (1995) Nature, 378, pp. 394-398
• Lenferink, A., Busse, D., Flanagan, W., Yakes, F., Arteaga, C., ErbB2/neu kinase modulates cellular p27(kip1) and cyclin D1 through multiple signaling pathways (2001) Cancer Res, 61, pp. 6583-6591
• Levitzki, A., Gazit, A., Tyrosine kinase inhibition: An approach to drug development (1995) Science, 267, pp. 1782-1788
• Lowell, B.B., PPARg: An essential regulator of adipogenesis andmodulator of fat cell function (1999) Cell, 99, pp. 239-242
• Mandrup, S., Lane, M.D., Regulating adipogenesis (1997) J Biol Chem, 272, pp. 5367-5370
• Menendez, J., Vellon, L., Mehmi, I., Oza, B., Ropero, S., Colomer, R., Lupu, R., Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells (2004) Proc Natl Acad Sci USA, 101, pp. 10715-10720
• Morrison, R.F., Farmer, S.R., (2000) Symposium: Adipocyte function, differentiation and metabolism. Hormonal signaling and transcriptional control of adipocyte differentiation. J Nutr, 130 (12), pp. 3116S-3121S
• Must, A., Spadano, E., Coakley, A., Field, A., Colditz, G., Dietz, W., The disease burden associated with overweight and obesity (1999) J Am Med Assoc, 282, pp. 1523-1529
• Nguyen, T., Scimeca, J., Filloux, C., Peraldi, P., Carpentier, J., Van Obberghen, E., Co-regulation of the mitogen-activated protein kinase, extracellular signal-regulated kinase 1, and the 90-kDa ribosomal S6 kinase in PC12 cells. Distinct effects of the neurotrophic factor, nerve growth factor, and the mitogenic factor, epidermal growth factor (1993) J Biol Chem, 268, pp. 9803-9810
• Olayioye, M.A., Update on HER-2 as a target for cancer therapy. Intracellular signaling pathways of ErbB2/HER-2 and family members (2002) Breast Cancer Res, 3, pp. 385-389
• Olayioye, M.A., Graus-Porta, D., Beerli, R.R., Rohrer, J., Gay, B., Hynes, N.E., ErbB-1 and ErbB-2 acquire distinct signaling properties dependent upon their dimerization partner (1998) Mol Cell Biol, 18, pp. 5042-5051
• Olayioye, M.A., Neve, R., Lane, H.A., Hynes, N.E., The ErbB signaling network: Receptor heterodimerization in development and cancer (2000) EMBO J, 19, pp. 3159-3167
• Pagano, E., Calvo, J.C., ErbB2 and EGFR are down-modulated during the differentiation of 3T3-L1 preadipocytes (2003) J Cell Biochem, 90, pp. 561-572
• Prusty, D., Park, B.-H., Davis, K.E., Farmer, S.R., Activation of MEK/ERK signaling promotes adipogenesis by enhancing peroxisome proliferator-activated receptor γ (PPARγ) and C/EBPα gene espression during the differentiation of 3T3-L1 preadipocytes (2002) J Biol Chem, 277, pp. 46226-46232
• Qian, X., Decker, S.J., Greene, M.I., p185neu and epidermal growth factor receptor associate into a strucutre composed of activated kinases (1992) Proc Natl Acad Sci USA, 89, pp. 1330-1334
• Reed BC, Kaufmann SH, Mackall JC, Student AK, Lane MD. 1977. Alterations in insulin binding accompaying differentiation of 3T3-L1 preadipocytes. Proc Natl Acad Sci USA 74:4876-4880; Schmidt, W., Pöll-Jordan, G., Löffler, G., Adipose convertion of 3T3-L1 cells in a serum-free culture system depends on epidermal growth factor, insulin-like growth factor-1, corticosterone, and cyclic AMP (1990) J Biol Chem, 265, pp. 15489-15495
• Schroeder, J.A., Lee, D.C., Dynamic expression and activation of ERBB receptors in the developing mouse mammary gland (1998) Cell Growth Differ, 9, pp. 451-464
• Serrero, G., EGF inhibits the differentiation of adipocyte precursors in primary cultures (1987) Biochem Biophys Res Commun, 146, pp. 194-202
• Serrero, G., Mills, D., Physiologic role of EGF on adipose tissue development in vivo (1991) Proc Natl Acad Sci USA, 88, pp. 3912-3916
• Smith, P.J., Wise, L.S., Berkowitz, R., Wan, C., Rubin, C.S., Insulin-like growth factor-1 is an essential regulator of the differentiation of 3T3-L1 adipocytes (1988) J Biol Chem, 263, pp. 9402-9408
• Wada, T., Qian, X., Greene, M.I., Intermolecular association of the p185neu protein and EGF receptor modulates EGF receptor function (1990) Cell, 61, pp. 1339-1347

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------